Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoporosis | 22 | 2023 | 74 | 5.610 |
Why?
|
| Osteoporotic Fractures | 7 | 2022 | 11 | 3.070 |
Why?
|
| Absorptiometry, Photon | 20 | 2022 | 78 | 2.910 |
Why?
|
| Bone Density | 22 | 2022 | 134 | 2.080 |
Why?
|
| Risk Assessment | 11 | 2022 | 578 | 1.460 |
Why?
|
| Bone Density Conservation Agents | 3 | 2022 | 12 | 1.340 |
Why?
|
| Femur Neck | 4 | 2017 | 18 | 1.160 |
Why?
|
| Osteoporosis, Postmenopausal | 3 | 2022 | 5 | 1.140 |
Why?
|
| Fractures, Bone | 7 | 2011 | 65 | 0.850 |
Why?
|
| Societies, Medical | 9 | 2013 | 113 | 0.800 |
Why?
|
| Diphosphonates | 3 | 2023 | 19 | 0.720 |
Why?
|
| Risk Factors | 12 | 2023 | 2179 | 0.630 |
Why?
|
| Practice Guidelines as Topic | 5 | 2013 | 243 | 0.580 |
Why?
|
| Calcaneus | 1 | 2017 | 4 | 0.570 |
Why?
|
| Congresses as Topic | 2 | 2013 | 31 | 0.540 |
Why?
|
| Ultrasonography | 2 | 2017 | 208 | 0.510 |
Why?
|
| Humans | 34 | 2023 | 25165 | 0.500 |
Why?
|
| Hip Fractures | 4 | 2023 | 23 | 0.470 |
Why?
|
| Patient Compliance | 1 | 2014 | 143 | 0.430 |
Why?
|
| Secondary Prevention | 3 | 2021 | 45 | 0.410 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 149 | 0.350 |
Why?
|
| Algorithms | 5 | 2021 | 338 | 0.350 |
Why?
|
| Jaw Diseases | 1 | 2009 | 1 | 0.320 |
Why?
|
| Osteonecrosis | 1 | 2009 | 16 | 0.320 |
Why?
|
| Collagen Type I | 1 | 2009 | 18 | 0.320 |
Why?
|
| Peptides | 1 | 2009 | 97 | 0.300 |
Why?
|
| Densitometry | 1 | 2007 | 9 | 0.290 |
Why?
|
| Spinal Fractures | 3 | 2017 | 43 | 0.270 |
Why?
|
| Spine | 1 | 2007 | 101 | 0.260 |
Why?
|
| Accidental Falls | 2 | 2021 | 108 | 0.250 |
Why?
|
| Lumbar Vertebrae | 2 | 2007 | 370 | 0.250 |
Why?
|
| Radiation Monitoring | 1 | 2005 | 1 | 0.240 |
Why?
|
| Safety Management | 1 | 2005 | 8 | 0.240 |
Why?
|
| Primary Prevention | 2 | 2017 | 26 | 0.240 |
Why?
|
| Retrospective Studies | 4 | 2023 | 3185 | 0.220 |
Why?
|
| Periprosthetic Fractures | 1 | 2023 | 25 | 0.210 |
Why?
|
| Denosumab | 1 | 2022 | 1 | 0.200 |
Why?
|
| Teriparatide | 1 | 2022 | 1 | 0.200 |
Why?
|
| Raloxifene Hydrochloride | 1 | 2022 | 1 | 0.200 |
Why?
|
| Alendronate | 1 | 2022 | 7 | 0.200 |
Why?
|
| Female | 9 | 2022 | 14161 | 0.180 |
Why?
|
| Guidelines as Topic | 2 | 2012 | 54 | 0.170 |
Why?
|
| Child | 6 | 2009 | 1211 | 0.170 |
Why?
|
| RNA, Messenger | 5 | 1990 | 293 | 0.170 |
Why?
|
| Cytochrome c Group | 3 | 1990 | 3 | 0.160 |
Why?
|
| Cytochromes c | 3 | 1990 | 10 | 0.160 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 1990 | 14 | 0.160 |
Why?
|
| Saccharomyces cerevisiae | 3 | 1990 | 20 | 0.160 |
Why?
|
| Middle Aged | 5 | 2022 | 8303 | 0.150 |
Why?
|
| Bone and Bones | 2 | 2009 | 108 | 0.140 |
Why?
|
| Finger Phalanges | 1 | 2017 | 2 | 0.140 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 15 | 0.140 |
Why?
|
| Cancellous Bone | 1 | 2017 | 5 | 0.140 |
Why?
|
| Protein Biosynthesis | 3 | 1988 | 15 | 0.140 |
Why?
|
| Radius | 1 | 2017 | 31 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 637 | 0.140 |
Why?
|
| Electronic Health Records | 1 | 2017 | 68 | 0.130 |
Why?
|
| United States | 1 | 2022 | 1928 | 0.130 |
Why?
|
| Canada | 2 | 2014 | 46 | 0.130 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 134 | 0.130 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2023 | 749 | 0.130 |
Why?
|
| Tibia | 1 | 2017 | 207 | 0.120 |
Why?
|
| Adult | 7 | 2022 | 7259 | 0.120 |
Why?
|
| Repressor Proteins | 2 | 1991 | 35 | 0.110 |
Why?
|
| Forensic Anthropology | 1 | 2014 | 1 | 0.110 |
Why?
|
| Adolescent | 4 | 2022 | 2018 | 0.110 |
Why?
|
| Nutrition Surveys | 1 | 2013 | 22 | 0.110 |
Why?
|
| ROC Curve | 1 | 2014 | 133 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2014 | 241 | 0.110 |
Why?
|
| Aged | 4 | 2022 | 8448 | 0.100 |
Why?
|
| Bone Diseases, Metabolic | 2 | 2010 | 16 | 0.100 |
Why?
|
| Trans-Activators | 2 | 1991 | 24 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2014 | 318 | 0.100 |
Why?
|
| Isopropyl Thiogalactoside | 1 | 1991 | 1 | 0.090 |
Why?
|
| Chimera | 1 | 1991 | 3 | 0.090 |
Why?
|
| Morbidity | 1 | 2011 | 50 | 0.090 |
Why?
|
| Male | 7 | 2014 | 13815 | 0.090 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2011 | 17 | 0.090 |
Why?
|
| Recurrence | 1 | 2012 | 274 | 0.090 |
Why?
|
| Health Status Indicators | 1 | 2010 | 70 | 0.080 |
Why?
|
| Primary Health Care | 1 | 2010 | 79 | 0.080 |
Why?
|
| Mutation | 3 | 1990 | 320 | 0.080 |
Why?
|
| World Health Organization | 1 | 2008 | 9 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2014 | 1772 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2009 | 138 | 0.070 |
Why?
|
| Pediatrics | 1 | 2008 | 33 | 0.070 |
Why?
|
| Observer Variation | 1 | 2007 | 89 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 73 | 0.070 |
Why?
|
| Software | 1 | 2007 | 58 | 0.070 |
Why?
|
| Reference Values | 1 | 2007 | 182 | 0.070 |
Why?
|
| Internet | 1 | 2007 | 86 | 0.070 |
Why?
|
| Biomarkers | 1 | 2009 | 520 | 0.060 |
Why?
|
| Incidence | 1 | 2008 | 704 | 0.060 |
Why?
|
| Thoracic Vertebrae | 1 | 2006 | 87 | 0.060 |
Why?
|
| Age Factors | 3 | 2010 | 712 | 0.050 |
Why?
|
| Base Sequence | 5 | 1990 | 104 | 0.050 |
Why?
|
| Transcription, Genetic | 3 | 1990 | 98 | 0.050 |
Why?
|
| Amino Acid Sequence | 4 | 1990 | 147 | 0.040 |
Why?
|
| Transcription Factors | 2 | 1990 | 157 | 0.040 |
Why?
|
| Reoperation | 1 | 2023 | 847 | 0.040 |
Why?
|
| HeLa Cells | 4 | 1991 | 42 | 0.040 |
Why?
|
| Alleles | 3 | 1990 | 211 | 0.040 |
Why?
|
| Molecular Sequence Data | 4 | 1990 | 186 | 0.030 |
Why?
|
| Kinetics | 2 | 1991 | 186 | 0.030 |
Why?
|
| Young Adult | 2 | 2009 | 1813 | 0.030 |
Why?
|
| Genes, Fungal | 2 | 1990 | 2 | 0.020 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1991 | 2 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 1991 | 19 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 27 | 0.020 |
Why?
|
| Mammals | 1 | 1991 | 24 | 0.020 |
Why?
|
| Temperature | 1 | 1991 | 60 | 0.020 |
Why?
|
| DNA | 1 | 1991 | 103 | 0.020 |
Why?
|
| Transfection | 1 | 1991 | 113 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2011 | 125 | 0.020 |
Why?
|
| Pacific Islands | 1 | 2010 | 2 | 0.020 |
Why?
|
| Asia | 1 | 2010 | 8 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2010 | 56 | 0.020 |
Why?
|
| Adenoviruses, Human | 1 | 1990 | 4 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 1990 | 30 | 0.020 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1990 | 5 | 0.020 |
Why?
|
| Genes, Viral | 1 | 1990 | 4 | 0.020 |
Why?
|
| Vitamin D | 1 | 2010 | 36 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1990 | 10 | 0.020 |
Why?
|
| Apoenzymes | 1 | 1990 | 1 | 0.020 |
Why?
|
| Apoproteins | 1 | 1990 | 1 | 0.020 |
Why?
|
| Isoenzymes | 1 | 1990 | 49 | 0.020 |
Why?
|
| Fractures, Spontaneous | 1 | 2009 | 8 | 0.020 |
Why?
|
| New Mexico | 1 | 2009 | 3 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1988 | 8 | 0.020 |
Why?
|
| Genes | 1 | 1988 | 7 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 1990 | 250 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1988 | 16 | 0.020 |
Why?
|
| Bone Development | 1 | 2008 | 30 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 1987 | 4 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 450 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1987 | 20 | 0.020 |
Why?
|
| Adenoviridae | 1 | 1987 | 13 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1987 | 35 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 1987 | 80 | 0.020 |
Why?
|
| Sex Factors | 1 | 2008 | 430 | 0.020 |
Why?
|
| Animals | 2 | 1991 | 3430 | 0.020 |
Why?
|
| Exercise | 1 | 2010 | 429 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2008 | 609 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 1985 | 2 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 4508 | 0.010 |
Why?
|
| Oligonucleotide Probes | 2 | 1990 | 4 | 0.010 |
Why?
|
| Operon | 1 | 1990 | 1 | 0.010 |
Why?
|
| Allosteric Regulation | 1 | 1990 | 3 | 0.010 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1990 | 4 | 0.010 |
Why?
|
| Simplexvirus | 1 | 1990 | 4 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1990 | 7 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1990 | 28 | 0.010 |
Why?
|
| Adenovirus Early Proteins | 1 | 1990 | 1 | 0.010 |
Why?
|
| Viral Structural Proteins | 1 | 1990 | 3 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 1990 | 26 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1990 | 42 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1990 | 47 | 0.010 |
Why?
|
| Polyribosomes | 1 | 1990 | 1 | 0.010 |
Why?
|
| DNA, Fungal | 1 | 1990 | 2 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1990 | 36 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 1990 | 87 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1990 | 54 | 0.010 |
Why?
|
| Thermodynamics | 1 | 1990 | 43 | 0.010 |
Why?
|
| Cell Line | 1 | 1990 | 251 | 0.010 |
Why?
|
| Genotype | 1 | 1990 | 338 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1987 | 9 | 0.000 |
Why?
|
| RNA Splicing | 1 | 1987 | 10 | 0.000 |
Why?
|
| Tubulin | 1 | 1987 | 16 | 0.000 |
Why?
|
| Biological Transport | 1 | 1987 | 39 | 0.000 |
Why?
|
| RNA, Viral | 1 | 1987 | 43 | 0.000 |
Why?
|